These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 9112650

  • 1. Comprehensive study on platelet function, hemostasis, fibrinolysis, peripheral serotonergic system and serum lipids in nephrotic syndrome.
    Małyszko J, Małyszko JS, Pawlak D, Pawlak K, Rydzewski A, Myśliwiec M, Buczko W.
    Pol J Pharmacol; 1996; 48(2):191-5. PubMed ID: 9112650
    [Abstract] [Full Text] [Related]

  • 2. Hemostasis, platelet function and serotonin in acute and chronic renal failure.
    Malyszko J, Malyszko JS, Pawlak D, Pawlak K, Buczko W, Mysliwiec M.
    Thromb Res; 1996 Sep 01; 83(5):351-61. PubMed ID: 8873344
    [Abstract] [Full Text] [Related]

  • 3. Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions.
    Zwaginga JJ, Koomans HA, Sixma JJ, Rabelink TJ.
    J Clin Invest; 1994 Jan 01; 93(1):204-11. PubMed ID: 8282789
    [Abstract] [Full Text] [Related]

  • 4. [Fibrinolytic and peripheral serotonergic system in patients with glomerulonephritis].
    Małyszko J, Małyszko J, Myśliwiec M, Pawlak D, Buczko W.
    Przegl Lek; 1995 Jan 01; 52(9):428-30. PubMed ID: 8834642
    [Abstract] [Full Text] [Related]

  • 5. A study of platelet functions, some hemostatic and fibrinolytic parameters in relation to serotonin in hemodialyzed patients under erythropoietin therapy.
    Malyszko J, Malyszko JS, Borawski J, Rydzewski A, Kalinowski M, Azzadin A, Mysliwiec M, Buczko W.
    Thromb Res; 1995 Jan 15; 77(2):133-43. PubMed ID: 7740505
    [Abstract] [Full Text] [Related]

  • 6. Platelet (dys)function and plasma plasminogen levels in hemodialysis patients.
    Salobir B, Sabovic M, Zupan IP, Ponikvar JB.
    Ther Apher Dial; 2008 Apr 15; 12(2):133-6. PubMed ID: 18387161
    [Abstract] [Full Text] [Related]

  • 7. Tissue-type plasminogen activator and fibrin monomers synergistically cause platelet dysfunction during retransfusion of shed blood after cardiopulmonary bypass.
    de Haan J, Schönberger J, Haan J, van Oeveren W, Eijgelaar A.
    J Thorac Cardiovasc Surg; 1993 Dec 15; 106(6):1017-23. PubMed ID: 8246533
    [Abstract] [Full Text] [Related]

  • 8. Relationships between serum lipids, serotonin, platelet aggregation and some fibrinolytic parameters in humans.
    Malyszko J, Urano T, Knofler R, Ihara H, Takada Y, Takada A.
    Life Sci; 1994 Dec 15; 55(21):1619-23. PubMed ID: 7968236
    [Abstract] [Full Text] [Related]

  • 9. Effects of a dried garlic preparation on fibrinolysis and platelet aggregation in healthy subjects.
    Legnani C, Frascaro M, Guazzaloca G, Ludovici S, Cesarano G, Coccheri S.
    Arzneimittelforschung; 1993 Feb 15; 43(2):119-22. PubMed ID: 8457236
    [Abstract] [Full Text] [Related]

  • 10. A study of fibrinogen and fibrinolysis in 10 adults with nephrotic syndrome.
    Gandrille S, Jouvin MH, Toulon P, Remy P, Fiessinger JN, Roncato M, Moatti N, Aiach M.
    Thromb Haemost; 1988 Jun 16; 59(3):445-50. PubMed ID: 3142081
    [Abstract] [Full Text] [Related]

  • 11. [Evaluation of selected parameters of hemostasis in patients with nephrotic syndrome].
    Rowiński M, Rydzewski A, Małyszko JS, Małyszko J, Myśliwiec M.
    Przegl Lek; 1994 Jun 16; 51(2):77-81. PubMed ID: 8058973
    [Abstract] [Full Text] [Related]

  • 12. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C.
    Clin Endocrinol (Oxf); 2006 Mar 16; 64(3):323-9. PubMed ID: 16487444
    [Abstract] [Full Text] [Related]

  • 13. Platelet hyperaggregability in the nephrotic syndrome which is not dependent on arachidonic acid metabolism or on plasma albumin concentration.
    Bennett A, Cameron JS.
    Clin Nephrol; 1987 Apr 16; 27(4):182-8. PubMed ID: 3107859
    [Abstract] [Full Text] [Related]

  • 14. Effects of endothelin-1 on aggregation of normal and uremic platelets.
    Pawlak K, Małyszko JS, Małyszko J, Myśliwiec M.
    Pol J Pharmacol; 1996 Apr 16; 48(2):185-90. PubMed ID: 9112649
    [Abstract] [Full Text] [Related]

  • 15. Platelet aggregation responses vary over a period of time in healthy controls.
    Refaai MA, Frenkel E, Sarode R.
    Platelets; 2010 Apr 16; 21(6):460-3. PubMed ID: 20536288
    [Abstract] [Full Text] [Related]

  • 16. Platelet survival and function in rats with enhanced thrombotic tendency.
    Delaini F, Dejana E, Reyers I, Vicenzi E, De Bellis Vitti G, Poggi A, Donati MB.
    Thromb Haemost; 1985 Dec 17; 54(4):739-43. PubMed ID: 3937273
    [Abstract] [Full Text] [Related]

  • 17. [Effect of treating glomerulonephritis with omega 3 fatty acids for selected parameters of hemostasis, blood platelet function and lipid metabolism].
    Małyszko JS, Małyszko J, Pawlak K, Myśliwiec M.
    Przegl Lek; 1996 Dec 17; 53(8):600-3. PubMed ID: 8999460
    [Abstract] [Full Text] [Related]

  • 18. Behaviour of fibrinolysis in the nephrotic syndrome.
    Cucuianu M, Manasia M, Spînu C, Mărcuşu C, Roman S, Comănescu A.
    Med Interne; 1988 Dec 17; 26(2):109-14. PubMed ID: 3133746
    [Abstract] [Full Text] [Related]

  • 19. Platelet serotonin and serum lipids in psychotic mania.
    Sagud M, Mihaljevic-Peles A, Pivac N, Jakovljevic M, Muck-Seler D.
    J Affect Disord; 2007 Jan 17; 97(1-3):247-51. PubMed ID: 16820211
    [Abstract] [Full Text] [Related]

  • 20. Impact of simvastatin on hemostatic and fibrinolytic regulators in Type 2 diabetes mellitus.
    Ludwig S, Dharmalingam S, Erickson-Nesmith S, Ren S, Zhu F, Ma GM, Zhao R, Fenton JW, Ofosu FA, Velthuis HT, van Mierlo G, Shen GX.
    Diabetes Res Clin Pract; 2005 Nov 17; 70(2):110-8. PubMed ID: 16188573
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.